We have developed a convergent and stereoselective synthesis of orally acti
ve renin inhibitor BILA 2157 BS. Three building blocks were used to generat
e the basic skeleton of the inhibitor. The key feature consisted of the lat
e elaboration of the 2-amino-4-thiazolyl heterocycle from a vinylbromide pr
ecursor. The synthetic sequence, which required a total of 22 chemical step
s, provided 0.6 kg of BILA 2157 BS in 7.3% overall yield.